HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ka-Loh Li Selected Research

Ka-Loh Li Research Topics

Disease

10Neoplasms (Cancer)
10/2021 - 10/2005
4Acoustic Neuroma (Acoustic Neurinoma)
01/2021 - 01/2014
3Breast Neoplasms (Breast Cancer)
12/2007 - 10/2005
2Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2018 - 02/2016
1Inflammation (Inflammations)
01/2019
1Glioblastoma (Glioblastoma Multiforme)
01/2018
1Meningioma (Meningiomas)
01/2014
1Necrosis
10/2005

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
05/2020 - 04/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2016 - 10/2005
2Phosphotransferases (Kinase)IBA
12/2007 - 04/2007
2Tyrosine Kinase InhibitorsIBA
12/2007 - 10/2005
2Tyrosine (L-Tyrosine)FDA Link
12/2007 - 04/2007
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2007 - 10/2005
2Axitinib (AG 013736)IBA
04/2007 - 10/2005
1Eosine Yellowish-(YS) (Eosin)IBA
10/2021
1Hematoxylin (Haematoxylon)IBA
10/2021
1PK 11195 (PK11195)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Fibrinogen (Factor I)FDA Link
01/2019
1Bevacizumab (Avastin)FDA Link
01/2018
1IceIBA
08/2012
1GadoliniumIBA
07/2008
1ErbB Receptors (EGF Receptor)IBA
12/2007
1Growth Factor ReceptorsIBA
12/2007
1Biological ProductsIBA
12/2007
1Gefitinib (Iressa)FDA Link
12/2007

Therapy/Procedure

5Therapeutics
01/2021 - 10/2005
1Microspheres (Microsphere)
01/2018
1Neoadjuvant Therapy
07/2008